MedTrace Logo

Follow-up Evaluation Using CT Scans in Patients Who Have Been Treated For Metastatic Testicular Cancer

NCT00553371 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2013-08-26

No results posted yet for this study

Summary

RATIONALE: Learning about long-term effects in patients with testicular cancer may help doctors plan better treatment and follow-up care.

PURPOSE: This clinical trial is using CT scans to follow patients who have been treated for metastatic testicular cancer.

Conditions

  • Testicular Germ Cell Tumor

Interventions

OTHER

biomarker analysis

PROCEDURE

computed tomography

Sponsors & Collaborators

  • Royal Marsden NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Robert A. Huddart, MD · Royal Marsden NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00553371 on ClinicalTrials.gov